Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19498
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHuang, Dora-
dc.contributor.authorMatin, Surena F-
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.authorRoupret, Morgan-
dc.date2018-
dc.date.accessioned2018-09-19T05:18:40Z-
dc.date.available2018-09-19T05:18:40Z-
dc.date.issued2018-07-30-
dc.identifier.citationBladder cancer (Amsterdam, Netherlands) 2018; 4(3): 261-268-
dc.identifier.issn2352-3727-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/19498-
dc.description.abstractLynch syndrome is an autosomal dominant disorder that predisposes individuals affected to certain malignancies. Colon and endometrial cancers are the malignancies most highly associated with Lynch syndrome. However, growing body of evidence links Lynch syndrome to urological cancers. This review aims to clarify the type of urological malignancies that fall under the Lynch-associated cancer spectrum. Using PRISMA guidelines, a systematic search between January 1990 to February 2018, was conducted using the MEDLINE database with the application of the following MESH terms: colorectal neoplasms, hereditary nonpolyposis; DNA mismatch repair; urologic neoplasms; kidney pelvis; ureteral neoplasms; urinary bladder; carcinoma, transitional cell; prostatic neoplasms; testicular neoplasms. Upper tract urothelial cancers are well established under the Lynch spectrum. Increasing evidence supports its association with prostate cancer. However, there is, inconclusive and limited evidence for an association with bladder and testicular cancer. The evidence underpinning certain urological malignancies associated with Lynch syndrome has expanded in recent years. Our review may assist in providing a summary of the current standing in literature. However, we recommend further investigations to better clarify associations, particularly with prostate, bladder and testicular cancer.-
dc.language.isoeng-
dc.subjectTesticular neoplasms-
dc.subjectColorectal neoplasms-
dc.subjectDNA mismatch repair-
dc.subjectcarcinoma-
dc.subjecthereditary nonpolyposis-
dc.subjectkidney pelvis-
dc.subjectprostatic neoplasms-
dc.subjecttransitional cell-
dc.subjectureteral neoplasms-
dc.subjecturinary bladder-
dc.subjecturologic neoplasms-
dc.titleSystematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.-
dc.typeJournal Article-
dc.identifier.journaltitleBladder cancer (Amsterdam, Netherlands)-
dc.identifier.affiliationSorbonne Université, GRC n° 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, F-75013 Paris, Franceen
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.affiliationDepartment of Urology, MD Anderson Cancer Center, Houston, TX, USAen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australiaen
dc.identifier.doi10.3233/BLC-180180-
dc.identifier.orcid0000-0001-8553-5618-
dc.identifier.pubmedid30112437-
dc.type.austinJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jan 29, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.